Clinical Trial Update: ALGRX 4975 in the Treatment of Tennis Elbow [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ALGRX 4975 for tennis elbow has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lateral Epicondylitis

Drugs mentioned

• ALGRX 4975

Snippet

Sponsor: AlgoRx Pharmaceuticals | Conditions: Tennis Elbow | Phase 2 | Status: COMPLETED